Carfilzomib and Lenalidomide With Dexamethasone Combination in Newly Diagnosed, Previously Untreated Multiple Myeloma

NCT01029054 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

53

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: carfilzomib, lenalidomide plus dexamethasone
DRUG: carfilzomib, lenalidomide plus dexamethasone

Sponsor

University of Michigan Rogel Cancer Center

Collaborators

[object Object]
[object Object]